These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4786936)

  • 21. [Determination of fibrinogen and fibrinolytic activity of the blood in lung cancer, chronic non-specific pneumonia and exudative pleuritis].
    Voprontsova GV
    Sov Med; 1967 May; 30(5):14-7. PubMed ID: 5612340
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on cryofibrinogen].
    Mizushina T
    Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):576-90. PubMed ID: 5292464
    [No Abstract]   [Full Text] [Related]  

  • 23. ABO blood groups in cancer of the gastro-intestinal tract.
    Rai S; Saronwala KC; Singh R
    Indian J Cancer; 1972 Mar; 9(1):97-100. PubMed ID: 5044717
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in metal and metalloprotein metabolism in the progression and treatment of malignant orbital tumors].
    Shkromida MI
    Oftalmol Zh; 1978; (6):410-4. PubMed ID: 568756
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of erythrocyte membranes from patients with neoplasms by the fluorescent probe method].
    Novitskiĭ VV; Stepovaia EA; Batukhtin AV; Gol'dberg VE; Kolosova MV
    Biull Eksp Biol Med; 1999 Aug; 127(8):226-9. PubMed ID: 11188751
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of surgical trauma on lipid metabolic indices in stomach and small intestine cancer patients].
    Breusenko EIa; Babadzhanov AS; Krasnova AI
    Vestn Akad Med Nauk SSSR; 1980; (2):24-7. PubMed ID: 7361515
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lipid composition of erythrocyte membranes in patients with cancer].
    Novitskiĭ VV; Stepovaia EA; Bazhenova NG; Gol'dberg VE; Kolosova MV; Saprykina EV; Gubert EA; Sokolova IB; Koreshkova KG; Bulavina IaV
    Biull Eksp Biol Med; 1998 Aug; 126(8):204-6. PubMed ID: 9777238
    [No Abstract]   [Full Text] [Related]  

  • 28. [Peripheral circulating lymphocytes in patients with cancer].
    Shirakami A; Iwao N; Imagawa T; Hashizume H; Kohama T
    Saishin Igaku; 1969 Aug; 24(8):1664-71. PubMed ID: 4902061
    [No Abstract]   [Full Text] [Related]  

  • 29. [Specific features of endogenous autorosette formation in the peripheral blood of cancer patients].
    Korichkina LN; Lavrinenko LV; Vinogradova TS; Salova NV; Gusakova GV
    Vopr Onkol; 2008; 54(1):62-4. PubMed ID: 18416060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correction of hypophyseal-adrenal system function in esophageal and stomach cancer patients undergoing combined and surgical treatments].
    Tartinov VI; Vinnitskiĭ VB; Ganul VL; Pridatko OE
    Vopr Onkol; 1983; 29(5):39-44. PubMed ID: 6190317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABO blood group distribution in relation to malignancies in Egypt.
    Hammouda F; Soliman HA; Hussein MH
    J Egypt Med Assoc; 1972; 55(8):655-60. PubMed ID: 4664110
    [No Abstract]   [Full Text] [Related]  

  • 32. Circulating levels of inhibin in cancer.
    Sheth NA; Hurkadli KS; Sathe VS; Sheth AR
    Neoplasma; 1984; 31(3):315-21. PubMed ID: 6204214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipid-bound sialic acids in the diagnosis of malignant neoplasms of the lungs and stomach].
    Surina AG; Tokarskaia ZB
    Lab Delo; 1986; (8):470-3. PubMed ID: 2429050
    [No Abstract]   [Full Text] [Related]  

  • 34. [Carbohydrate metabolism in neoplastic processes].
    Miloslavskiĭ IM; Dyshlevaia LN; Buntser IaM
    Vopr Onkol; 1972; 18(3):74-8. PubMed ID: 5017842
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatocyte growth factor in the sera of patients with gastrointestinal and breast cancer].
    Narita T; Toi M; Sekiguchi K; Iwanari H; Matsuura N; Kimura N; Mitsuoka C; Kannagi R
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2159-62. PubMed ID: 9388530
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum copper and ceruloplasmin levels in patients with neoplasias localized in the stomach, large intestine or lung.
    Scanni A; Licciardello L; Trovato M; Tomirotti M; Biraghi M
    Tumori; 1977; 63(2):175-80. PubMed ID: 898288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of fibrinogen level in neoplastic and other diseases of the lung].
    Lukaszczyk E; Radecki A; Ignasiak J
    Pol Tyg Lek; 1969 Jun; 24(25):957-60. PubMed ID: 5805056
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood groups & diseases.
    POLLARA C; MELINA D
    Riforma Med; 1957 Aug; 71(33):929-31. PubMed ID: 13485867
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnostic value of the plasma fibrinogen livel in lung cancer].
    Sosnowski K; Niewiadomska S; Sierawski S
    Pol Tyg Lek; 1968 Jun; 23(26):977-8. PubMed ID: 5669731
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with the treatment of patients with malignant tumors with 5-fluorouracil].
    Milonov BV; Kosarev VA; Nikiforov AM
    Vopr Onkol; 1967; 13(12):55-61. PubMed ID: 5597532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.